To assess the effects of oncolytic Ads on the CD4+CD25+Foxp3+ Treg cell population, we examined draining lymph nodes (DLNs) from tumor-bearing mice by fluorescence-activated cell sorting (FACS). The gene discussed is CD4; the disease is neoplasm.